The mini-BioProducer hollow fiber membrane cartridges are designed for small to medium scale production, for batch volumes between 5L to 250L and are also the perfect choice for scale up studies to Maximizer multicartridge systems with membrane
The mini-BioProducer hollow fiber membrane cartridges are designed for small to medium scale production, for batch volumes between 5L to 250L and are also the perfect choice for scale up studies to Maximizer multicartridge systems with membrane
The mini-BioProducer hollow fiber membrane cartridges are designed for small to medium scale production, for batch volumes between 5L to 250L and are also the perfect choice for scale up studies to Maximizer multicartridge systems with membrane
The mini-BioProducer hollow fiber membrane cartridges are designed for small to medium scale production, for batch volumes between 5L to 250L and are also the perfect choice for scale up studies to Maximizer multicartridge systems with membrane
The mini-BioProducer hollow fiber membrane cartridges are designed for small to medium scale production, for batch volumes between 5L to 250L and are also the perfect choice for scale up studies to Maximizer multicartridge systems with membrane
The mini-BioProducer hollow fiber membrane cartridges are designed for small to medium scale production, for batch volumes between 5L to 250L and are also the perfect choice for scale up studies to Maximizer multicartridge systems with membrane
The BioProducer series is a group of hollow fiber cartridges specifically designed for clarification and concentration applications in the biopharmaceutical market utilizing the WaterSep antifouling, high capacity polyethersulfone (PES) membrane.
The BioProducer series is a group of hollow fiber cartridges specifically designed for clarification and concentration applications in the biopharmaceutical market utilizing the WaterSep antifouling, high capacity polyethersulfone (PES) membrane.
The mini-BioProducer hollow fiber membrane cartridges are designed for small to medium scale production, for batch volumes between 5L to 250L and are also the perfect choice for scale up studies to Maximizer multicartridge systems with membrane
The mini-BioProducer hollow fiber membrane cartridges are designed for small to medium scale production, for batch volumes between 5L to 250L and are also the perfect choice for scale up studies to Maximizer multicartridge systems with membrane
BDNF is suitable as a control for polyclonal or monoclonal anti-BDNF in immunological assays. Biological Activity: The activity is determined by the dose-dependent proliferation of C6 cells and is typically between 0.5-1.5 µg/mL.
BDNF is suitable as a control for polyclonal or monoclonal anti-BDNF in immunological assays. Biological Activity: The activity is determined by the dose-dependent proliferation of C6 cells and is typically between 0.5-1.5 µg/mL.
Anti-DIG is a his-tagged monoclonal recombinant antibody designed to detect digoxigenin and its conjugates. This antibody is intended for use in immunological assays including ELISA, western blotting, immunofluorescence and fluorescence activated
Anti-DIG is a his-tagged monoclonal recombinant antibody designed to detect digoxigenin and its conjugates. This antibody is intended for use in immunological assays including ELISA, western blotting, immunofluorescence and fluorescence activated
RFP Control is suitable as a control for polyclonal or monoclonal Anti-RFP in immunological assays. The molecular weight of RFP (calculated) is 27 kDa, but in a gel it is expected to run at approximately 28-30 kDa.
RFP Control is suitable as a control for polyclonal or monoclonal Anti-RFP in immunological assays. The molecular weight of RFP (calculated) is 27 kDa, but in a gel it is expected to run at approximately 28-30 kDa.
AKT3 is suitable as a control for polyclonal or monoclonal anti-AKT3 in immunological assays. Akt3 recombinant protein is expected to be phosphorylated and in an active state.
AKT3 is suitable as a control for polyclonal or monoclonal anti-AKT3 in immunological assays. Akt3 recombinant protein is expected to be phosphorylated and in an active state.
AKT2 is suitable as a control for polyclonal or monoclonal anti-AKT2 in immunological assays. Akt2 recombinant protein is expected to be phosphorylated and in an active state.
AKT2 is suitable as a control for polyclonal or monoclonal anti-AKT2 in immunological assays. Akt2 recombinant protein is expected to be phosphorylated and in an active state.